Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Loqtorzi™ (toripalimab-tpzi) – New orphan drug approval
October 27, 2023 - Coherus and Junshi Biosciences announced the FDA approval of Loqtorzi (toripalimab-tpzi) for the treatment of nasopharyngeal carcinoma.
